Month: May 2025

Form 8.3 – [GLOBALDATA PLC – 30 04 2025] – (CGWL)

Written by Customer Service on May 1, 2025. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree GLOBALDATA PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position held/dealing...

Alpha Modus Holdings Enters into Funding Agreement in Connection with Broadcom Patent Infringement Lawsuit, Secures Option to Acquire Alpha Modus Ventures

Written by Customer Service on May 1, 2025. Posted in Public Companies.

Alpha Modus Ventures sues Broadcomover breakthrough technologies for transporting Fibre Channel data over Ethernet.CORNELIUS, N.C., May 01, 2025 (GLOBE NEWSWIRE) — Alpha Modus Holdings, Inc. (Nasdaq: AMOD), a leader in AI-driven retail technology , today announced it has executed a patent monetization and funding agreement with Alpha Modus Ventures, LLC, the entity that recently filed a patent infringement lawsuit against Broadcom Inc on April 22, 2025. Under the terms of the agreement, Alpha Modus Holdings, Inc. (AMOD) will fund litigation efforts related to the enforcement by Alpha Modus Ventures, LLC (an entity controlled by the CEO of Alpha Modus Holdings, Inc., William Alessi) of U.S. Patent Nos. 11,108,591; 11,303,473; and 11,310,077, which cover breakthrough technologies for transporting Fibre Channel data over...

Form 8.3 – [GLOBALDATA PLC – Opening Disclosure – 30 04 2025] – (CGAML)

Written by Customer Service on May 1, 2025. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree GLOBALDATA PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position...

NOTICE OF VIRTUAL ANNUAL GENERAL MEETING OF COINSHARES INTERNATIONAL LIMITED ON 30 MAY 2025

Written by Customer Service on May 1, 2025. Posted in Public Companies.

Notice is hereby given that the Annual General Meeting of CoinShares International Limited (the “Company”) will take place on Friday, 30 May 2025 at 14:00 BST in the form of a hybrid virtual event at 2 Hill Street, St Helier, Jersey, JE2 4UA. The entire Annual General Meeting will be broadcast live online (audio and video) via Wavecast.io and will be open for all shareholders who are entered in the Company’s stock register on the record day of the Annual General Meeting. The exercise of shareholder rights, in particular the exercise of voting rights, requires registration for the meeting in due time and in the proper form and will be performed by poll during the meeting or by granting power of attorney to Company proxies. The location of the Annual General Meeting for the purposes of the minutes is the Company’s registered office, 2 Hill...

Akari Therapeutics Appoints Mark F. Kubik as Head of Business Development – Oncology

Written by Customer Service on May 1, 2025. Posted in Public Companies.

Global expertise in establishing and executing transformative transactions which have led to multiple approved therapeutic products Successful track record across oncology therapeutics including ADCs and antibody therapies ranging from early discovery to pre-clinical/clinical stage 25+ year-career experience bolsters Company’s efforts to address growing, high-value ADC market and maximize opportunities for non-dilutive capital BOSTON and LONDON, May 01, 2025 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced the appointment of Mark F. Kubik as Head of Business Development – Oncology. Mr. Kubik is a well-established industry leader whose oncology expertise and transactions record has led to multiple approved...

NANO Nuclear Announces Opening Keynote Presentation and Platinum Sponsorship at the Upcoming Reuters Events: SMR & Advanced Reactor 2025 Conference

Written by Customer Service on May 1, 2025. Posted in Public Companies.

Figure 1NANO Nuclear Energy Inc. Chief Executive Officer to Lead Opening Keynote Presentation at the Reuters Events: SMR & Advanced Reactor 2025 to be held on May 12-13, 2025.New York, N.Y., May 01, 2025 (GLOBE NEWSWIRE) — NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear energy and technology company focused on developing clean energy solutions, today announced that it is the Platinum Sponsor of the upcoming Reuters Events: SMR & Advanced Reactor 2025, to be held in Nashville, Tennessee on 12-13, May 2025. NANO Nuclear Energy Chief Executive Officer James Walker will lead the opening keynote presentation titled, “The Growth of U.S. Advanced Reactors — Wall Street’s Success Story” at 9:00am on May 12th. In the presentation, he will explore how U.S. policy...

Pharmacorp Completes Acquisition of Pre-1954 Charter Company in Ontario

Written by Customer Service on May 1, 2025. Posted in Mergers And Acquisitions.

SASKATOON, Saskatchewan, May 01, 2025 (GLOBE NEWSWIRE) — PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) is pleased to announce that, further to its news release dated April 3, 2025, it has completed the acquisition of all issued and outstanding shares of a pre-1954 charter company (the “Charter Company”) in Ontario, Canada (the “Acquisition”). The Acquisition of the Charter Company is an arm’s length transaction and no finder’s fees were paid in respect of the Acquisition. The Acquisition of the Charter Company represents a major milestone for PharmaCorp. As previously disclosed, due to ownership restrictions under the Drug and Pharmacies Regulations Act (Ontario), a corporation that is not owned by pharmacists – including a public company – may not own or operate a pharmacy in Ontario unless it operates through...

Douglas Dynamics Announces Board Leadership Transition

Written by Customer Service on May 1, 2025. Posted in Public Companies.

Lead Director Don Sturdivant Appointed Chairman of the Board, Jim Janik to Continue Serving as Director MILWAUKEE, Wis., May 01, 2025 (GLOBE NEWSWIRE) — Douglas Dynamics, Inc. (NYSE: PLOW), North America’s premier manufacturer and upfitter of work truck attachments and equipment, today announced a planned board leadership transition. Current Chairman of the Board, James (Jim) L. Janik, has decided to step down from his role as Chairman, effective April 30, 2025. Mr. Janik will continue to serve as a member of the Board of Directors, ensuring a smooth transition and continued strategic oversight. The Board of Directors has appointed Don Sturdivant, the current Lead Director, to succeed Mr. Janik as Chairman. “Jim has been a tremendous leader for Douglas Dynamics, guiding the Company through significant milestones for decades in...

Cohen & Company Reports First Quarter 2025 Financial Results

Written by Customer Service on May 1, 2025. Posted in Dividend Reports And Estimates.

Board Declares Quarterly Dividend of $0.25 per Share PHILADELPHIA and NEW YORK, May 01, 2025 (GLOBE NEWSWIRE) — Cohen & Company Inc. (NYSE American: COHN), a financial services firm specializing in an expanding range of capital markets and asset management services, today reported financial results for its first quarter ended March 31, 2025. Summary Operating Results Three Months Ended($ in thousands) 3/31/25 12/31/24 3/31/24 Net trading $ 9,211 $ 8,947 $ 9,848 Asset management 2,020 2,067 2,717 New issue and advisory 33,239 10,075 24,388 Principal transactions and other revenue (15,730 ) (2,548 ) (18,389 )Total revenues 28,740 18,541 18,564 Compensation and benefits 21,666 12,935 14,839 Non-compensation...

Brera Holdings (Nasdaq: BREA) Highlights Innovative Public Ownership Model as Wall Street Journal Recognizes Growing Impact of U.S. Investors in Global Football

Written by Customer Service on May 1, 2025. Posted in Public Companies.

Brera’s Strategy of Sustainable Growth and Local Engagement Reflects Evolving Industry Best Practices, Including Bottom-Up Value CreationWhile Hollywood stars Rob McElhenney (left) and Ryan Reynolds’ (right) club Wrexham was a U.K.mid-table 5th division team at the time of their acquisitionWhile Hollywood stars Rob McElhenney (left) and Ryan Reynolds’ (right) club Wrexham was a U.K.mid-table 5th division team at the time of their acquisition, Brera invested in Juve Stabia when it reached Serie B, the 2nd division of Italian football, after promotion from Serie CWhile Hollywood stars Rob McElhenney (left) and Ryan Reynolds’ (right) club Wrexham was a U.K.mid-table 5th division team at the time of their acquisition, Brera invested in Juve Stabia when it reached Serie B, the 2nd division of Italian football, after promotion from...

Month: May 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals